{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:28:52Z","timestamp":1777591732216,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.idcr.2023.e01688","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T13:08:20Z","timestamp":1673269700000},"page":"e01688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Severe hyponatraemia with cerebral oedema after Pfizer BNT162b2 mRNA vaccination against COVID-19"],"prefix":"10.1016","volume":"31","author":[{"given":"J.F.M.","family":"Dharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Montalto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fourlanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2023.e01688_bib1","unstructured":"Pfizer COVID-19 vaccine safety data \u2013 all participants; Available from: \u3008https:\/\/ausvaxsafety.org.au\u3009."},{"issue":"3","key":"10.1016\/j.idcr.2023.e01688_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20080140","article-title":"Gender and renal function influence plasma levels of copeptin in healthy individuals","volume":"116","author":"Bhandari","year":"2009","journal-title":"Clin Sci"},{"issue":"4","key":"10.1016\/j.idcr.2023.e01688_bib3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40620-021-01036-8","article-title":"Hyponatremia is associated with poor outcome in COVID-19","volume":"34","author":"De Carvalho","year":"2021","journal-title":"J Nephrol"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01688_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","article-title":"Copeptin in the differential diagnosis of hyponatremia","volume":"94","author":"Fenske","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01688_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ekir.2017.08.015","article-title":"Hyponatremia and the brain","volume":"3","author":"Gankam Kengne","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01688_bib6","doi-asserted-by":"crossref","first-page":"09","DOI":"10.3390\/medicina57010055","article-title":"Is there a relationship between COVID-19 and hyponatremia?","volume":"57","author":"Gheorghe","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.idcr.2023.e01688_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01688_bib8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1186\/s12879-021-06690-8","article-title":"The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case report","volume":"21","author":"Lindner","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01688_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.idcr.2023.e01688_bib10","article-title":"A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine","volume":"9","author":"Murvelashvili","year":"2021","journal-title":"J Invest Med High Impact Case Rep"},{"issue":"3","key":"10.1016\/j.idcr.2023.e01688_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/cen.13243","article-title":"Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: 'the Co-MED study'","volume":"86","author":"Nigro","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01688_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cen.13991","article-title":"Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis","volume":"91","author":"Refardt","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.idcr.2023.e01688_bib13","article-title":"Urinary retention and severe hyponatremia: an unusual presentation of COVID-19","volume":"7","author":"Saleh","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"issue":"20","key":"10.1016\/j.idcr.2023.e01688_bib14","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2021.19499","article-title":"Association between mRNA vaccination and COVID-19 hospitalization and disease severity","volume":"326","author":"Tenforde","year":"2021","journal-title":"Jama"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250923000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250923000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:05:59Z","timestamp":1761998759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250923000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":14,"alternative-id":["S2214250923000124"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01688","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe hyponatraemia with cerebral oedema after Pfizer BNT162b2 mRNA vaccination against COVID-19","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01688"}}